Eduardo Fernandez serves as Chairman of the Board of Chancellors for the American College of Radiation Oncology. He has published two doctoral theses as well as numerous book chapters and articles. He has lectured in more than 100 topics all over the world. He has been recognized by the Florida Medical Association as Distinguished Physician and the Florida Diversity Council with the Multicultural Leadership Award. Dr. Fernandez is a fellow of the American College of Radiation Oncology and the American Society for Therapeutic Radiation Oncology. He is also on faculty at U.C.L.A. where he serves as Assistant Professor in Radiation Oncology. Dr. Fernandez has been a member of GenesisCare since 1998, with numerous administrative roles and currently is the Medical Director of the International Program.
Career Positions
Current position(s)
- GenesisCare - National Medical Director, Plantation, FL
Past position(s)
- American College of Radiation Oncology - Vice President and Board of Chancellors
- Aventura Hospital - Chief of Radiation Oncology, Aventura, FL
- Cleveland Clinic Florida - Head of Radiation Oncology, Dual Appointment at Main Campus of Cleveland Clinic Foundation, Weston, FL
Education
Universities
- University of Malaga (European Union), PhD, Malaga, Spain
- University of Malaga (European Union), Doctor of Medicine, Malaga, Spain
Residencies
- Cleveland Clinic Foundation, Radiation Oncology, Cleveland, OH
Internships
- Cleveland Clinic Foundation, Medical, Surgical, Cleveland, OH
Expertise And Interests
Interests
- Prostate, Breast, Lung, Colorectal, Head and Neck, Brain and Spine Tumors
Professional associations
Accomplishments
Awards and honors
- Multicultural Leadership Award - Florida Diversity Council; Honorary Member of the Radiation Therapy Society of the Dominican Republic; Leader in Medicine Award - Florida Medical Association; Distinguished Physician - Florida Medical Association; Two doct
Publications
- Protection by Fluoride against Phthalocyanine induced photodynamic killing of Chinese Hamster Cells
- Comparative Study of Ion F-Mediated Inhibition on Nuclear DNA Photodynamic Damage Induced by Dihematoporphyryn Ether and Chloro-aluminum-phthalocyanine in V-79 Cells
- Analysis of Toxicity In a Group of Patients Treated for Pancreatic Cancer with Combined Modality 3-D Radiation Therapy
View 1 more
Presentations
Z120920142
Dioval A. Remonde, BS, Ron R. Allison,MD, Sharon A. Salenius, MPH, Andrej Hnatov, MD, Cynthia Ballenger, MD, Constantine A. Mantz, MD, Eduardo Fernandez,MD,PhD, Steven E. Finkelstein,MD, 2015, ARS
View PresentationZ120920141
Francisco A. Myslicki, Jesse Shulman, Sharon Salenius, Neal Shore, Constantine Mantz, Eduardo Fernandez, Steven E. Finkelstein, 20158, ARS
View PresentationZ091420169
Lacombe J, McClain K, Gonzales P, Fernandez E, Galmarini D, Dosoretz D, Zenhausern F, Finkelstein SE., 2016, ACRO
View PresentationZ091420167
Finkelstein SE, Salenius S, Cross CK, Allison RR, Shafman T, Mantz C, Fernandez E, 2016, ASCO
View PresentationZ091420162
Finkelstein SE, Forman J, Fernandez E, Chen C, Lieberfarb M, Salenius SA, Shafman T, and Mantz CA, 2016, ASTRO
View PresentationZ083120151
Martinez A, Olivera G, Ghilezan M, Forman J, Kestin L, Finkelstein S, Mo X, Key S, Mantz C, Fernandez E, Galmarini D, et al., 2015, ASTRO Annual Meeting
View PresentationZ061520158
Myslicki FA, Salenius SA, Rotterman YW, Mantz CA, Finkelstein SE, Fernandez E., 2015, ACRO Annual Meeting
View PresentationZ061520154
Allison R, Salenius SA, Hnatov A, Ballenger D, Lichtblau D, Mantz CA, Fernandez E, Finkelstein SE, 2015, ASTRO Annual Meeting
View PresentationZ061520151
Kestin L, Fernandez E, Mantz C, Olivera G, Mo X, Key S, Finkelstein SE, Martinez A, Galmarini D., 2015, ASTRO Annual Meeting
View PresentationZ12020161
Anesa W. Ahamad, Sharon Salenius, Chaundre K. Cross, Ron R. Allison, Eduardo B. Fernandez, 2016, ACRO
View PresentationZ11120172
Mantz Constantine, Wallner Paul, Fernandez Eduardo B., Salenius Sharon, 2017, AAPM Spring Clinical Meeting
View PresentationZ2920162
Ron R. Allison, Sharon A. Salenius, Andrej Hnatov, Cynthia Ballenger, Anesa Ahamad, Constantine A. Mantz, Eduardo Fernandez, Steven E. Finkelstein, 2016, American Radium Society 100th Anniversary Meeting
View PresentationZ2920161
Anesa Ahamad, Donald Weed, Darel Pruett, Daniel Saulpaugh, Eduardo Fernandez, 2016, American Radium Society’s 100th Anniversary Meeting
View Presentation61520157
Myslicki FA, Salenius SA, Shore ND, Mantz CA, Fernandez E, Finkelstein SE, 2015, ACRO Annual Meeting
View Presentation View 14 more
Clinical studies
Primary Objective - To determine whether men with NCCN high risk prostate cancer who are in the lower 2/3 of Decipher genomic risk (< 0.85) can be treated with 12 months ADT plus RT instead of 24 months ADT+RT and experience non-inferior metastasis-free survival.
View Study